His primary scientific interests are in Immunology, SuPAR, Internal medicine, Tuberculosis and Antigen. His Immunology study combines topics from a wide range of disciplines, such as Plasminogen activator, Proportional hazards model, Disease and Cohort. His SuPAR research incorporates themes from Inflammation, C-reactive protein, Cancer and Prospective cohort study.
Internal medicine is often connected to Gastroenterology in his work. In his research, Pathology, T cell, Biomarker and Latent tuberculosis is intimately related to Whole blood, which falls under the overarching field of Tuberculosis. He combines subjects such as Survival analysis and Interferon gamma with his study of Antigen.
His primary areas of study are SuPAR, Internal medicine, Immunology, Biomarker and Inflammation. Jesper Eugen-Olsen interconnects Cancer and Disease in the investigation of issues within SuPAR. His biological study spans a wide range of topics, including Gastroenterology and Endocrinology.
Immunology is closely attributed to Tuberculosis in his research. His research integrates issues of Prospective cohort study and Intensive care medicine in his study of Biomarker. His work in Viral disease addresses issues such as Acquired immunodeficiency syndrome, which are connected to fields such as Genotype.
His scientific interests lie mostly in SuPAR, Internal medicine, Biomarker, Hazard ratio and Anakinra. His studies in SuPAR integrate themes in fields like Inflammation, Interquartile range and Respiratory failure. His Internal medicine study frequently draws connections to adjacent fields such as Gastroenterology.
His Biomarker research is multidisciplinary, incorporating perspectives in Endocrinology and Blood pressure. His Coronavirus disease 2019 study which covers Symptom onset that intersects with Immunology. His Immunology study integrates concerns from other disciplines, such as Plasma samples and Polymerase chain reaction.
The scientist’s investigation covers issues in SuPAR, Internal medicine, Biomarker, Hazard ratio and Urokinase Plasminogen Activator. His SuPAR study necessitates a more in-depth grasp of Receptor. His Internal medicine study frequently involves adjacent topics like Diabetes mellitus.
His studies deal with areas such as Clinical nutrition, Proportional hazards model, Risk of mortality and Population study as well as Hazard ratio. His Urokinase Plasminogen Activator research incorporates elements of Immunology, Respiratory failure, Betacoronavirus and Pneumonia. His work carried out in the field of Body mass index brings together such families of science as Young adult, Cohort study and C-reactive protein.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
suPAR: the molecular crystal ball.
Maria Thunø;Betina Macho;Jesper Eugen-Olsen.
Disease Markers (2009)
Effects of CCR5-Δ 32, CCR2-64I, and SDF-1 3′A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data
J. P.A. Ioannidis;P. S. Rosenberg;J. J. Goedert;L. J. Ashton.
Annals of Internal Medicine (2001)
Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
Kristian Kofoed;Ove Andersen;Gitte Kronborg;Michael Tvede.
Critical Care (2007)
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.
J. Eugen‐Olsen;O. Andersen;A. Linneberg;S. Ladelund.
Journal of Internal Medicine (2010)
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P carinii pneumonia
Jannik Helweg-Larsen;Thomas L Benfield;Jesper Eugen-Olsen;Jens D Lundgren.
The Lancet (1999)
Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals.
Jesper Eugen-Olsen;Astrid K.N. Iversen;Peter Garred;Uffe Koppelhus.
AIDS (1997)
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection.
Nicolai Sidenius;Cornelis F. M. Sier;Henrik Ullum;Bente Klarlund Pedersen.
Blood (2000)
Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
Troels K. H. Scheel;Judith M. Gottwein;Tanja B. Jensen;Jannick C. Prentoe.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis
M. Ruhwald;T. Bodmer;C. Maier;M. Jepsen.
European Respiratory Journal (2008)
Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.
L Andresen;V L Jørgensen;A Perner;A Hansen.
Gut (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Copenhagen University Hospital
Bandim Health Project, Denmark
University of Copenhagen
Steno Diabetes Center
Radboud University Nijmegen
Copenhagen University Hospital
National and Kapodistrian University of Athens
University of Copenhagen
University of Copenhagen
Statens Serum Institut
The University of Texas at Austin
Hewlett-Packard (United States)
University of New Orleans
University of Pisa
Xi'an Jiaotong University
Argonne National Laboratory
North Dakota State University
American Museum of Natural History
Colorado State University
Ruhr University Bochum
Tufts University
United States Geological Survey
Virginia Tech
Sophia University
University of Maryland, College Park
Duke University